miércoles, 28 de diciembre de 2016

[Drug Compounding Draft Guidances]: Compounding and repackaging of radiopharmaceuticals

fda header

Today FDA issued two draft guidances on compounding and repackaging of radiopharmaceuticals:

The comment period on the draft guidances closes in 60 days. Information on how to comment on the guidances is available in the Federal Register:


FDA’s website has additional information on compounding.

No hay comentarios:

Publicar un comentario